Active, Not Recruiting
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
NCT04140526
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
- Locations
-
- Highlands Oncology Group Springdale, Arkansas, United States
- University of California at Davis Davis, California, United States
- The Oncology Institute of Hope and Innovation Downey, California, United States
- City of Hope Cancer Center Duarte, California, United States